Mean SPAG5 expression value was higher in ER- than ER+ breast cancer patients (mean value 434.48 vs. 602.64, p <  0.001), similar trend was also observed in PR- and HER2+ breast cancer patients. This evidence concerns the gene SPAG5 and breast carcinoma.